Short-term effects of dapagliflozin on biomarkers of bone and mineral metabolism in patients with diabetic kidney disease: A prospective observational study Tugba Islek; Safak Mirioglu; Meltem Gursu; Rumeyza Kazancioglu; Metin Demirel; Sahabettin Selek; Omer Celal Elcioglu;

Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology Nuria Montero; Laia Oliveras; Alberto Martínez-Castelao; José Luis Gorriz; María José Soler; Beatriz Fernández-Fernández; Maria Quero; Clara García-Carro; Paula Garcia-Sancho; Marian Goicoechea; Juan Jose Gorgojo Martínez; Pablo Molina; María Jesús Puchades; Diana Rodríguez-Espinosa; Nery Sablón; Rafael Santamaría; Juan Francisco Navarro-González;

Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis Juan Francisco Navarro-González; Alberto Ortiz; Ana Cebrián Cuenca; Lluís Segú; Belén Pimentel; Unai Aranda; Blanca Lopez-Chicheri; Margarita Capel; Elisenda Pomares Mallol; Christian Caudron; Juan José García Sánchez; Roberto Alcázar Arroyo;